Learning Objectives:

• The basic concepts of pharmacokinetics and pharmacodynamics.
• Describe the clinical implications of how drug disposition changes in the newborn period with maturation.
• Apply basic PK principles to improve drug dosing to achieve targeted serum concentrations for desired effect.

Learning Objectives:

• Describe recent pharmacokinetic findings in infants for antifungals.
• Describe recent safety findings in infants for antifungals.
• Describe recent dosing recommendation for treatment of Candida meningoencephalitis.

Speaker Disclosure:

Shionogi
Cempra
Abbvie

Speaker Relationship:

Contract
Contract
Consultant

Learning Objectives:

• Review Postnatal Glucose Homeostasis and Transitional Neonatal Hyperinsulinemia.
• Discuss approaches to define Hypoglycemia in the Neonate.
• Learn strategies to screen and manage low glucose levels as well as address ways to identify Persistent Hypoglycemic Syndromes.

Learning Objectives:

• Recognize at least 2 potential medication errors in the NICU.
• Describe at least one practice to reduce medication errors in the NICU.
• Describe how inattentional blindness can contribute to medication errors.

Learning Objectives:

• Describe recent pharmacokinetic findings in infants for antibiotics.
• Describe recent safety findings in infants for antibiotics.
• Describe factors influencing choice of empirical antibiotic therapy for hospitalized infants.

Learning Objectives:

• Determine the current definition of vitamin D health.
• Identify the evidence regarding vitamin D status and vitamin D intake for infants.
• Determine methods to optimize vitamin D health of hospitalized infants.

Learning Objectives:

• Describe the mechanism of action of commonly used sedatives.
• Describe the concern regarding neurodevelopmental outcome and medication exposure.
• Identify differences in drug metabolism unique to neonates.

Learning Objectives:

• Determine the evidence-based practice of preterm infant feeding.
• Identify the evidence regarding additives to human milk.
• Determine the most efficacious and safest methods to feed preterm infants.

Learning Objectives:

• Know survival rates for VLBW infants.
• Be aware of risks and benefits of antenatal corticosteroids for late preterm infants.
• Know the importance of preventing hemorrhagic disease of the newborn.

Learning Objectives:

• Review nutritional strategies with higher protein to energy ratios to prevent postnatal growth failure.
• Evaluate the data on prevention of NEC with human milk, probiotics and lactoferrin.
• Look at newer products and strategies to improve the fortification of human milk for VLBW infants.